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Abstract
Filamins (FLNs) are large, multidomain actin cross-linking proteins with diverse functions.
Besides regulating the actin cytoskeleton, they serve as important links between the extra-
cellular matrix and the cytoskeleton by binding cell surface receptors, functioning as scaf-
folds for signaling proteins, and binding several other cytoskeletal proteins that regulate cell
adhesion dynamics. Structurally, FLNs are formed of an amino terminal actin-binding
domain followed by 24 immunoglobulin-like domains (IgFLNs). Recent studies have dem-
onstrated that myosin-mediated contractile forces can reveal hidden protein binding sites in
the domain pairs IgFLNa18–19 and 20–21, enabling FLNs to transduce mechanical signals
in cells. The atomic structures of these mechanosensor domain pairs in the resting state are
known, as well as the structures of individual IgFLN21 with ligand peptides. However, little
experimental data is available on how interacting protein binding deforms the domain pair
structures. Here, using small-angle x-ray scattering-based modelling, x-ray crystallography,
and NMR, we show that the adaptor protein migfilin-derived peptide-bound structure of
IgFLNa20–21 is flexible and adopts distinctive conformations depending on the presence or
absence of the interacting peptide. The conformational changes reported here may be com-
mon for all peptides and may play a role in the mechanosensor function of the site.
Introduction
Filamins (FLNs) are large, multi-domain rod-like proteins initially found to crosslink actin fila-
ments that regulate the stability and viscoelastic properties of the actin cytoskeleton [1]. Since
their discovery, knowledge about their cellular functions has been broadened by the discovery
of a wide array of interacting partners with diverse functions. These include transmembrane
receptors, intracellular signaling molecules, and cytoskeletal proteins. Thus, FLNs link the
extracellular matrix to the cytoskeleton, function as a scaffold during signaling events, and reg-
ulate cell adhesion dynamics [2–4]. Recently, it has become evident that FLNs also detect local
physical forces and play a role in the mechanosensing that helps cells to respond to mechanical
cues [5–12].
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In vertebrates, the FLN family comprises three highly conserved proteins: FLNa, FLNb, and
FLNc. FLNa is the most abundant and widely expressed isoform along with FLNb, whereas the
expression of FLNc is more restricted [13]. FLNs are composed of an N-terminal actin-binding
domain followed by a string of 24 filamin immunoglobulin domains (IgFLNs), typically
divided into rod 1 and 2 through two flexible hinge regions between domains 15–16 and 23–
24, respectively (Fig 1A) [1,13]. The most C-terminal IgFLN mediates self-association, thus
forming a dimer needed in the cross-linking of actin filaments [14]. The other IgFLNs function
as interaction modules. The majority of the known interacting partners have been mapped to
bind the rod 2 domains, whereas domains 9–15 of rod 1 have a secondary actin-binding site
[2,4,15].
IgFLNs are β sandwiches in which seven β strands are assembled into two β sheets [13]. The
face formed by the C and D strands forms a general ligand-binding interface [12,16]. Currently,
in all known heteromolecular complex structures of IgFLNs, the peptide ligands interact with a
mechanism called β sheet augmentation, in which the peptide forms an additional antiparallel
β strand next to the C strand of IgFLNs (Fig 1B) [12,16–21]. The dimerization interface of
IgFLN24 is mediated by β sheet augmentation through the β strand D [14,22].
Fig 1. Structures of FLNs. A A schematic representation of FLN dimer. An N-terminal actin binding domain
(ABD) is followed by 24 Ig-like repeats that are traditionally divided into two rods separated by a small flexible
hinge in between. The most C-terminal repeat mediates the dimerization. The colored domains were studied
here.B Ligands bind to IgFLNs via β sheet augmentation. Structure of migfilin peptide (blue) bound to the CD
face of IgFLNa21 (green) (PDB ID:2W0P) [18]. C–D, Structures of FLNmechanosensor modules, IgFLNa18–
19 (2K7Q) [24] and IgFLNa19–21 (2J3S) [23]. The A strands of IgFLNa18 (yellow) and 20 (cyan) bury the
ligand binding interfaces of IgFLNa19 (magenta) and 21 (green).
doi:10.1371/journal.pone.0136969.g001
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Structural studies have shown that not all IgFLNs are arranged linearly as beads-on-a-string,
but form multidomain modules whose functions are not always known (Fig 1A) [21,23–26].
IgFLNa18–19 and 20–21 have an exceptional inter-domain interaction in which the first β
strand of the preceding domain folds along the ligand-binding face (i.e. the CD face) of the fol-
lowing domain, mimicking the β sheet-forming peptide ligands (Fig 1C and 1D). This arrange-
ment has been shown to auto-inhibit ligand binding [23] and to provide a mechanism for
mechanical regulation, where external forces can unfold the masking β strand and enable
ligand binding [8,9,12]. The mechanical regulation of these mechanosensor domain pairs has
been recently verified [10] and shown to take place within physiological force rates generated
by myosin [27,28].
The ligand-binding to individual IgFLN domains has been extensively studied [12]. How-
ever, it is not known how the interacting protein binding deforms the structure of mechanosen-
sor domain pairs. To address this question, we performed small-angle x-ray scattering (SAXS)
studies for IgFLNa20–21 with a cell adhesion regulation-related adaptor protein migfilin [29]
peptide. In addition, we solved the crystal structure of IgFLNa20–21 lacking the ligand-binding
inhibitory β strand, called hereafter IgFLNaΔA20–21, in the complex with the peptide. The
study revealed that the peptide-bound structure is flexible and adopts distinctive conforma-
tions from the unbound form or the one lacking the inhibitory β strand.
Materials and Methods
Recombinant proteins
The IgFLNa20–21 (residues 2141–2329 according to domain boundaries in [13]) and
IgFLNaΔA20–21 (2151–2329) fragments were generated by polymerase chain reaction and
cloned into a modified pGEX vector (GE Healthcare). The inserts were verified by sequencing.
The glutathione S-transferase fusion proteins were expressed in Escherichia coli BL21 cells at
37°C for 4 h. The cells were lysed at 2000 PSI using a French Pressure Cell Press (Thermo
Fisher Scientific). The lysates were centrifuged at 48000g for 30 min and subsequently purified
with Glutathione Sepharose 4 Fast Flow (GE Healthcare) according to the manufacturer’s
instructions. Glutathione S-transferase was cleaved with tobacco etch virus protease at 4°C for
16 h and removed from the solution with the Glutathione Sepharose. The proteins were further
purified with size-exclusion chromatography in 20 mM Tris at pH 8.0, 100 mMNaCl, and 1
mMDTT using a Superdex 75 HR 26/60 column (GE Healthcare) on an Äkta Prime FPLC sys-
tem (GE Healthcare), and finally concentrated using Amicon Ultra-15 (Millipore) filter units.
The purity of the proteins was confirmed with SDS-PAGE and the monodispersity was verified
with analytical gel filtration using a Superdex 75 HR 10/30 column (GE Healthcare).
Small-angle x-ray scattering
SAXS data were collected at the European Synchrotron Radiation Facility (Grenoble, France),
beamline BM29 [30] (S1 Table). The data were collected at 277 K in 20 mM Tris (pH 8.0), 100
mMNaCl, and 10 mM DTT using 1–4 mg/ml concentrations of IgFLNa20–21 and
IgFLNaΔA20–21. Two times molar excess of the migfilin peptide was used to ensure saturation
in binding. The small size of the peptide enabled direct subtraction of its scattering when
applied also to the sample buffer. A PILATUS 1M image plate was used, at a sample/detector
distance of 2.85 m and wavelength of 0.10 Å, covering the momentum transfer range of 0.01<
q< 5 nm-1 (q = 4ᴨsin(θ)/λ where 2θ is the scattering angle). The data were processed using the
standard procedures of the ATSAS program package [31]. Buffer subtractions were conducted
with PRIMUS [32]. The radius of gyration Rg was estimated with AUTORG [33] and distance
distribution functions P(r) and particle maximum dimension Dmax were estimated using
Crystal Structure of IgFLNa20-21-Migfilin Complex
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DATGNOM [34]. DATPOROD was used to estimate the excluded volume (Vp) of the
hydrated particle [31]. Dimensionless Kratky (qRg2 x I(q)/I(0) versus qRg for Vc normalized
and qVc2 x I(q)/I(0) versus qVc for volume-of-correlation Vc normalized) [35] and Porod–
Debye (q4 x I(q) versus q4) [36] plots were used to assess the flexibility of the proteins. Vc was
calculated with the program SCÅTTER [37]. The bead-modeling program DAMMIF [38] was
used to generate an ab initiomodel of IgFLNa20–21. Ten individual runs of DAMMIF were
performed and averaged with DAMAVER [39]. CRYSOL [40] was used to evaluate the scatter-
ing of the IgFLNa20–21 crystal structure (from IgFLNa19–21 crystal structure, PDB ID: 2J3S)
[23]. SUPCOMB [41] was used to overlay the crystal structure and the ab initiomodel with
minimal normalized spatial discrepancy. An ensemble optimization method (EOM) [42] was
used to further model the inter-domain flexibility and size distribution in solution. First, a pool
of 10,000 randomly generated models of IgFLNa20–21 and IgFLNaΔA20–21 were generated
with the RanCh program. The inter-domain linker (residues 2230–2236) and IgFLNa20 A
strand (residues 2141–2150) were considered to be random chains. Then, a genetic algorithm
program, GAJOE, was used to select an ensemble of 20 models whose combined scattering best
fit with the experimental scattering. The data along with the ab initiomodel were submitted to
SASBDB [43].
Crystallography
IgFLNaΔA20–21 in complex with migfilin peptide (5PEKRVASSVFITLAPPRR DVAVAE28,
EZBiolab, Westfield, IN) was crystallized using the hanging drop vapor diffusion method at
295 K with an equimolar (1 mM) protein-peptide mixture. Next, 2 μl droplets containing equal
volumes of the protein-peptide mixture and 0.1 MMES at pH 6, 1.9 M (NH4)2SO4, 0.1 M
(CH3CO2)3Pr were equilibrated against 1 ml of the reservoir solution. The crystals were trans-
ferred to 25% glycerol in the reservoir solution before freezing under liquid nitrogen. The data
were collected at 100 K at the European Synchrotron Radiation Facility (Grenoble, France),
beamline ID14–1, using the ADSC Q210 CCD detector, and were processed using the XDS
program package [44]. The crystal structure was solved by molecular replacement with Phaser
[45] using the structure of IgFLNa21 (PDB code: 2W0P, A chain) [18] as a search model. The
model was built using ARP/wARP [46] and Coot [47] and refined using REFMAC 5.5 [48].
TLS refinement parameters were defined with help of the TLSMD server [49]. Final refinement
was made using the PDB-REDO server to optimize the refinement parameters [50]. Structural
factors and atomic coordinates were deposited in the PDB with ID 4P3W. All crystallographic
figures were generated with PyMOL (Schrödinger LCC, Portland, OR).
NMR
Migfilin peptide binding was monitored by acquiring a 1H, 15N HSQC spectrum of samples
with protein-to-peptide concentration ratios of 1:0.0, 1:0.5, 1:1, 1:3, and 1:5. Backbone chemical
shift assignment was performed for free IgFLNΔAa20–21 and the 1:5 IgFLNaΔA20–21:migfilin
complex with HNCACB and CBCA(CO)NH spectra, the latter having phase-inverted signals
for Cβ of residues Ala, Ile, Val, Thr, and Cα of Gly. 15N T1 and T2 relaxation data were acquired
with the following time points: 10, 60, 110, 330, 660, 920, 1200, 1500, 2100, and 2700 ms, and
additionally 3500 ms for the complex (T1) and 10, 30, 50, 70, 90, and 110 ms (T2). An exponen-
tially decaying curve was fitted to the peak intensities, as implemented in the program Sparky
(T.D. Goddard and D.G. Kneller, SPARKY 3, University of California, San Francisco). To
study amide protection, the protein sample in H2O was lyophilized and subsequently dissolved
in D2O. The exchange was followed by a series of
1H, 15N HSQC spectra, extending to 23 h for
the free form and to 63 h for the complex form. The time before the start of the first spectrum
Crystal Structure of IgFLNa20-21-Migfilin Complex
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was approximately 18 min. All aforementioned spectra were recorded at 30°C on a Varian
INOVA 800 MHz spectrometer equipped with a cryogenically cooled 1H, 13C, 15N z-gradient
probehead. Diffusion data was recorded at 30°C on a Bruker AVANCE III HD 600 MHz spec-
trometer equipped with a 1H, 13C, 15N z-gradient cryoprobe. Gradient strength range was 2.4
to 47.2 G/cm. The data were analyzed with the built-in Dynamics Center program using inten-
sities of manually picked peaks.
Results
Migfilin binding changes the conformation of IgFLNa20–21
To study how the interacting protein binding deforms the structure of the IgFLNa20–21
mechanosensor domain pair, we performed extensive SAXS measurements with a model pep-
tide derived from migfilin. All measurements were done in three different protein concentra-
tions and the Guinier analysis indicated no apparent particle aggregation or repulsion (S1 Fig).
The SAXS-derived structural parameters of each concentration and the combined data are
given in Table 1. The molecular weights calculated from the Porod volumes (Vp) indicate
monomeric species in both the absence and presence of migfilin peptide.
The analysis of the SAXS data showed that IgFLNa20–21 is a compact structure in solution.
The shape of the distance distribution function P(r) is a bell-shaped curve typical for a globular
particle. The x-ray structure of IgFLNa20–21 (taken from the structure of IgFLNa19–21, PDB
ID: 2J3S [23]) fits moderately to the scattering curve of IgFLNa20–21 (χ2 = 2.2, S2 Fig). Even
though the published structure of IgFLNa20–21 lacks some loops, the addition of these loops
Table 1. SAXS derived structure parameters for IgFLNa20–21 and IgFLNaΔA20–21 with and without boundmigfilin peptide.
Sample c (mg/ml) Rg (nm)a Dmax (nm)b Vp (nm3)c Mw (kDa)d
IgFLNa20-21 1 1.9 6.7 32.7 19.2
2.5 2.0 7.0 32.0 18.8
4 2.0 6.9 32.2 18.9
1.9 6.8 32.0 18.8
IgFLNa20-21+migﬁlin 1 2.3 8.0 33.3 19.6
2.5 2.3 8.1 34.3 20.2
4 2.4 8.4 35.0 20.6
2.3 8.2 32.9 19.4
IgFLNaΔA20-21 1 2.4 8.5 27.8 16.4
2.5 2.4 8.5 28.1 16.5
4 2.4 8.4 28.1 16.5
2.4 8.5 28.9 17.0
IgFLNaΔA20-21+migﬁlin 1 2.4 8.5 31.0 18.2
2.5 2.5 8.4 31.0 18.2
4 2.5 8.6 30.6 18.0
2.4 8.2 31.1 18.3
The values showed in bold are for the merged scattering data of high and low concentration for each sample. See related S2 Table for additional
parameters.
a From Guinier analysis.
b Estimate from P(r) calculation in DATGNOM [34]
c Estimated from the regularized scattering obtained from P(r) calculation in DATPOROD [31].
d Estimated from the hydrated particle volume Vp by dividing the volume by 1.7 [31]. Calculated monomeric molecular weights from sequence are
approximately 20.0 kDa for IgFLNa20–21, 18.7 kDa for IgFLNaΔA20–21, and 2.6 kDa for the migﬁlin5–28 peptide.
doi:10.1371/journal.pone.0136969.t001
Crystal Structure of IgFLNa20-21-Migfilin Complex
PLOS ONE | DOI:10.1371/journal.pone.0136969 August 31, 2015 5 / 19
does not change the fit to the SAXS data. The Dmax (6.4 nm) measured from the x-ray structure
is well in accordance with that obtained from the SAXS data (6.8 nm). In Fig 2A, the crystal
structure of IgFLNa20–21 is overlaid with the averaged ab initio envelope of IgFLNa20–21 cal-
culated from the SAXS data.
Migfilin binding led to notable changes in IgFLNa20–21 structural parameters. Both the
Guinier plots and the distance distribution function P(r) showed that both Rg and Dmax are
increased upon peptide binding (Fig 2B and 2C, Table 1). Also, the shape of P(r) of IgFLNa20–
21 is shifted from the typical bell-shaped curve of a globular particle into a more extended
curve, suggesting a conformational change.
Based on earlier structural studies [25,51], it is apparent that part of the ligand-induced con-
formation changes of IgFLNa20–21 may be caused by the displacement of the first β strand of
IgFLNa20 by the ligand. To study these and other changes caused by peptide ligands, we also
analyzed a two-domain fragment lacking the first β strand, IgFLNaΔA20–21. SAXS measure-
ments showed that IgFLNaΔA20–21 was significantly more elongated than IgFLNa20–21
(Table 1 and Fig 2). The shape of P(r) of IgFLNaΔA20–21 in the absence of peptide was similar
Fig 2. Standard analysis of SAXS data. A Ab initiomodeling of IgFLNa20-21. The averaged ab initiomodel (in magenta) is overlaid with the envelope of all
individual ab initiomodels superposed with minimal normalized spatial discrepancy (in gray). The crystal structure of IgFLNa20–21 (from 2J3S [23] is
superposed to the averaged ab initiomodel. B Experimental scattering and Guinier fits (inlet), C Distance distribution function P(r), D Rg normalized Kratky
plots (for Vc normalized Kratky plots, see S3 Fig), and E Porod-Debye plots of IgFLNa20–21 and IgFLNaΔA20–21 with and without migfilin peptide. The data
is shown for the merged scattering of high and low concentration data scaled to same forward scattering intensity I(0) except for Guinier plots which are
arbitrarily displaced on the y axis for clarity.
doi:10.1371/journal.pone.0136969.g002
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to that of IgFLNa20–21 in the presence of peptide. Peptide addition did not significantly alter
the P(r) of IgFLNaΔA20–21 (Fig 2C). The slightly bi-modal shapes of the P(r) curves suggest
that in IgFLNa20–21 with the peptide and in IgFLNaΔA20–21 with or without the peptide, the
two domains may be separated.
Migfilin binding increases the conformational flexibility of IgFLNa20–21
The lack of domain-domain interactions might be apparent as flexibility of the particles in
SAXS. To study this, the SAXS data was analyzed using dimensionless (normalized with Rg or
volume-of-correlation Vc) Kratky and Porod–Debye plots. In the dimensionless Kratky plot,
the increase in flexibility is seen as a skewing of the parabolic shape of the curve [35,36]. The
plots suggests that either migfilin binding or removal of the A strand increases the flexibility of
the domain pair (Fig 2D; S3 Fig). In the presence of the peptide, both constructs show almost
identical profiles, whereas without the peptide, IgFLNa20–21 is significantly more compact
than IgFLNaΔA20–21 (Fig 2D). Similar behavior of these two constructs was observed also in
the Porod–Debye plot, where the loss of a Porod plateau at low q angles is an indication of
structural flexibility [36]. A clear plateau can be observed in the Porod–Debye plot of
IgFLNa20–21 in the absence of peptide (Fig 2E), whereas with the bound peptide, no plateau
can be seen, indicating increased flexibility upon peptide binding. For IgFLNaΔA20–21, no pla-
teau is seen in the absence or presence of the peptide (Fig 2E).
Solution-state modelling of peptide-bound IgFLNa20–21
Kratky and Porod–Debye plots showed that the peptide-bound IgFLNa20–21 and
IgFLNaΔA20–21 with or without peptide are flexible. Thus, traditional ab initio and rigid-body
modeling techniques are not suitable for such particles with multiple conformations. There-
fore, EOM analysis of the SAXS data was used to further model the conformational space of
the two-domain fragments with and without peptide (Fig 3). Based on the EOM analysis,
IgFLNa20–21 is mainly in a compact conformation with average Rg and Dmax of 2.0 nm and
6.6 nm, respectively (Fig 3). Rg and Dmax values are very similar to those obtained from the
Guinier plots and P(r) function, and a similar Dmax value can also be measured from the crystal
structure of IgFLNa20–21. Interestingly, EOM-selected conformations also included a minor
population of extended conformations with peaks in Rg and Dmax around 2.8 nm and 8.5 nm,
respectively. This explains the moderate fit of the IgFLNa20–21 crystal structure to the scatter-
ing data, as the scattering computed from the structure only represents the compact conforma-
tion (see above). Migfilin peptide-binding to IgFLNa20–21 changed the shape of the size
distribution of the EOM-selected population compared to the non-bound one. With bound
peptide, the size distribution of selected conformations is wide, with an average Rg and Dmax of
2.3 nm and 7.5 nm, respectively (Fig 3). Accordingly, peptide binding to IgFLNa20–21 opens
the compact two-domain fragment, also making it simultaneously more flexible, as the size dis-
tribution covers a wider range than without peptide.
The ΔA strand construct behaved differently in the EOM analysis than did the IgFLNa20–
21 fragment. Without bound peptide, the EOM-selected population of IgFLNaΔA20–21 with a
bimodal size distribution had one peak around 2.1 nm (Rg) and 7.0 nm (Dmax) and another
around 2.6 nm (Rg) and 8.5 nm (Dmax). This suggests that IgFLNaΔA20–21 adopts two confor-
mations in solution. The EOM-produced models are shown in Fig 3. Interestingly, peptide-
binding to IgFLNaΔA20–21 changes the size distribution of the EOM-selected conformations
from bimodal to unimodal. The size distribution is wide and very similar to that of IgFLNa20–
21, with bound peptide having peaks at 2.3 nm (Rg) and 7.5 nm (Dmax). Thus, the EOM
Crystal Structure of IgFLNa20-21-Migfilin Complex
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analysis of the SAXS data suggests that in the presence of bound peptide, both IgFLNa20–21
and IgFLNaΔA20–21 populate a similar and rather wide conformation space.
Crystal structure of IgFLNaΔA20–21 in complex with migfilin peptide
To obtain atomic detail information on structural changes caused by peptide-binding to the
two domain fragments, we crystallized IgFLNaΔA20–21 in complex with the migfilin peptide.
The A strand deletion construct was used to avoid unstructured sequences that might inhibit
crystallization. The crystals belonged to the R3 space group, and diffraction data up to 2.0 Å
resolution were used (Table 2). The asymmetric unit contained six copies of IgFLNaΔA20–21
assembled into three dimers (Fig 4A). In each dimer, the IgFLN polypeptide chains were
crossed together by two migfilin peptides in between. In the final model, all six IgFLNaΔA20–
21 molecules were nearly identical to each other (root-mean-square deviations of 0.0.6–0.39 Å
for 139 Cα atoms). The greatest variation was seen at the loop regions of IgFLNa20 and at the
inter-domain loop (Fig 4B). In chains A, B, C, and E, all loops in IgFLNa20 could be modeled,
but in chains D and F, the electron density of loops between β strands of B–C and D–E was too
poor to model these loops completely. The chains A, B, C, and E provide the first complete
structure of domain 20 in isoform A, because in the earlier structure, many loops were missing
Fig 3. EOMmodelling of migfilin peptide binding on IgFLNa(ΔA)20–21. Left panels, Fit from the selected ensemble of conformers to the experimental
scattering. Radius of gyration, Rg (middle panels), and particle maximum dimension, Dmax (right panels), distribution histograms of the selected conformers
versus the pool. Also shown in the right panel are examples of rigid body models of the selected conformers corresponding to the histogram peaks.
doi:10.1371/journal.pone.0136969.g003
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as well [23]. The complete IgFLNa20 structure is similar to the previously solved NMR struc-
ture of the same domain in isoform B (PDB ID: 2DLG; root-mean-square deviation of 1.19
for 61 Cα atoms) (Fig 4C). The final R-factors of the refined IgFLNaΔA20–21 structure were
Rwork = 20.0 and Rfree = 22.6. The structure fits only moderately with the experimental scatter-
ing of IgFLNaΔA20–21+migfilin (χ2 = 2.7, S2 Fig). This is in line with the flexibility analyses
(Fig 2D and 2E) and EOMmodelling (Fig 3), according to which the domain pair is flexible
and adopts a rather wide range of different conformations.
Migfilin residues 8–18 bind to the CD face of IgFLNa21 in the IgFLNaΔA20–21 construct,
and prolines 19–20 bind to the top of domain 21, displacing domain 20 from the position seen
in the crystal structure of FLNa19–21 [23] (Fig 5). These prolines do not form any interactions
with IgFLNa21, but solely provide the necessary kink for the peptide to bind on top of the
domain. Migfilin binding to the CD face is similar to that of the isolated domain 21 [18,52]
(root-mean-square deviation of 0.36 Å for 89 atoms). Here we are also able to see migfilin resi-
dues 6–7, which were not seen in previous published structures [18,52]. However, these resi-
dues do not form any interactions with domain 21, although Lys7 together with Arg8 are
thought to be important for the interaction with FLN [18,29].
Table 2. Data collection and refinement statistics for IgFLNaΔA20–21-migfilin complex structure.
Parameter Statistic
Data collection
Wavelength 0.93
Space group R3
Cell dimensions
a, b, c (Å) 88.15, 88.15, 394.71
α, β, γ (°) 90, 90, 120
Resolution range (Å) 43.86–2.00 (2.05–2.00)
Number of observations
Total unique 76 965
Completeness (%) 99.6 (99.8)
Redundancy 3.65 (3.64)
σ 18.59 (2.18)
Rmeas (%) 5.0 (58.2)
CC0.5 (%) 99.9 (83.3)
Reﬁnement
Resolution range (Å) 43.86–2.00
Number of reﬂections work/test set 73 110/3863
Rwork/Rfree 20.0/22.6
Deviation from ideal stereochemistry (RMSD)
Bond lengths (Å) 0.02
Angles (°) 2.00
Ramachandran plot (%)
Favored 98
Allowed 2
Outliers 0
Wilson B-factor (Å2) 40.6
PDB accession code 4P3W
The outer shell data are shown in parentheses.
doi:10.1371/journal.pone.0136969.t002
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NMR analysis of IgFLNaΔA20–21
To obtain more information about the flexibility and interactions of IgFLNaΔA20–21, NMR
measurements were performed without and with various concentrations of the migfilin pep-
tide. Assignment was achieved with HNCACB and CBCA(CO)NH spectra. In addition, NMR
diffusion data, 15N T1 and T2 relaxation data, as well as deuterium exchange data, were
analyzed.
The NMR analysis of IgFLNaΔA20–21 in the presence of migfilin peptide suffered consider-
ably from the disappearance of a large fraction of the IgFLNaΔA20 HSQC peaks upon peptide-
binding. Most likely, this was due to severe line-broadening caused by an emerging exchange
phenomenon in the intermediate, μs–ms timescale. No line-broadening is observed in the
IgFLNa21 HSQC peaks, meaning that the observed peptide-induced exchange phenomenon is
not caused by interdomain dynamics. Loss of the IgFLNaΔA20 peaks made it impossible to
map changes at the interdomain interface. In spite of this, the NMR data could be used to eval-
uate the size of the protein, the binding site in IgFLNa21, and the domain-level flexibility of the
protein.
The NMR diffusion data were used to deduce the radii of hydration for the free and pep-
tide-bound IgFLNaΔA20–21. Radii of hydration derived from these data were 19.7±0.3 Å for
the free form and 17.8±1.5 Å for the bound form. These values are in accordance with the
Fig 4. Crystal structure of IgFLNaΔA20–21-migflin peptide complex. A The asymmetric unit. FLN chains
are colored in yellow and grey, and migfilin chains in magenta.B All six IgFLNaΔA20–21 chains of the
asymmetric unit superimposed. All chains are nearly identical with each other. The greatest variation is seen
in the inter-domain loop and at the loop regions of IgFLNa20 (shown with the black arrows). IgFLNa20 is
colored in cyan, IgFLNa21 in green, and migfilin peptide in yellow.C Superimposition of IgFLNa20 (in cyan)
from the crystal structure reported here and IgFLNb20 NMR structure (in gray) (2DLG). The structures are
similar with CD faces adopting a closed conformation.
doi:10.1371/journal.pone.0136969.g004
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values of 21.7 Å(free)/22.5 Å (bound) predicted from the number of residues [53] for a mono-
mer. For the radius of hydration of a dimer, the prediction gives 26.4/27.4 Å.
To further measure the size and flexibility parameters of the domains, 15N T1 and T2 relaxa-
tion times were measured from free and peptide-bound IgFLNaΔA20–21 (S4 Fig). A plot of
15N T1/T2 versus the amino acid sequence is shown in Fig 6A. The average T1/T2 ratios are
noticeably different for domains IgFLNaΔA20 and IgFLNa21, suggesting that the domains
show no fixed relative orientation. In the absence of the peptide, the rotational correlation
times of the individual domains, τc, derived from the
15N T1/T2 ratios [54], were 9.8±0.2 ns for
ΔA20 and 10.6±0.2 ns for 21. In the presence of peptide, the τc values were 11.9±0.2 ns for
ΔA20 and 13.4±0.2 ns for 21. All of these values are significantly larger than those predicted
Fig 5. Migfilin peptide binding on IgFLNaΔA20–21. A Comparison of IgFLNa21-migfilin complex structure
(peptide shown in orange) [18] (2W0P) with the structure reported here. Only the CD face and peptide are
shown.B Electron density map (Fo–Fc) of migfilin peptide shown at σ level 2.5 calculated from the refined
model without the peptide.C Same as panel B with peptide shown.DMigfilin peptide binding causes major
conformational changes in IgFLNa20–21. The left panel shows the compact structure of IgFLNa20–21 from
2J3S [23]. On the right panel, the current structure and the compact structure (2J3S) are superimposed for
IgFLNa21 and the compact conformation of IgFLNa20 is shown surface rendered. The two proline residues
in the migfilin peptide (shown in sticks) cause a steric clash (red) for the compact orientation of IgFLNa20.
The peptide sequence is given below. Density for the amino acids in the peptide written in gray was not seen.
doi:10.1371/journal.pone.0136969.g005
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based on the molecular weight of the individual domains (4.8 ns for ΔA20, 5.2 ns for 21, and
6.6 ns for 21+migfilin). The change of the domain-specific τc values upon peptide addition
may be simply explained by the interaction of the peptide with IgFLNa21. The results suggest
that the linkage between the two domains notably reduces the overall tumbling rates but allows
for some interdomain flexibility. This is in accordance with the SAXS analysis presented above
and has been observed and quantified for the wild-type domain pair when part of a larger
assembly, IgFLNa16–21 [26].
To characterize the IgFLNaΔA20–21-migfilin interaction, we performed a peptide titration
experiment and measured the peptide-induced chemical shift perturbations (Fig 6B, S5 Fig). In
accordance with the crystal structure, significant chemical shift perturbations were located on
the CD face of the IgFLNa21 domain and in the areas in immediate contact with the C and D
Fig 6. NMR spectroscopy of 15N-IgFLNaΔA20–21. A T1/T2 for free (open circles) and migfilin-bound
(closed circles) 15N-IgFLNaΔA20–21. For each domain the average value is shown with a horizontal line.
Domain linker region is indicated with a red bar.B Chemical shift perturbations in 15N-IgFLNaΔA20–21 upon
titration with migfilin peptide. Residues corresponding to the β strands are shown with the red bars. Shift
changes of Δδ > 0.1 ppm are shown in the structure of IgFLNa21 in red. Residues with no data are assigned
an arbitrary value -0.02 ppm.
doi:10.1371/journal.pone.0136969.g006
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strands. Upon titration, peaks of the free form disappear and those of the bound form appear
as the peptide concentration is increased. Free and bound-form peaks are of approximately
equal intensity in the HSQC spectrum acquired at a 1:1 protein-to-peptide ratio. These features
are consistent with slow exchange in the NMR timescale, which is indicative of tight binding
between IgFLNa21 and migfilin.
To gain more information about the structural dynamics in IgFLNaΔA20–21, H/D-
exchange experiments were performed (S6 Fig). The initial data point in these experiments was
acquired 18 min after solvent exchange. In the initial HSQC spectrum of the free form, there
were 17 peaks from domain ΔA20. Only nine of these peaks were present in the initial spec-
trum of the bound form. This is in contrast to the situation in IgFLNa21. Here, the complex
form of this domain was significantly more resistant to H/D exchange than that of the free
form. The protected amide HSQC peaks of the complex form are clearly visible 63 h after the
addition of D2O, whereas those of the free form vanish in less than 23 h. Increased protection
is observed throughout the domain, not only at the immediate vicinity of the binding site. This
suggests that the peptide brings additional stability to the whole IgFLNa21 domain.
Taken together, the NMR analysis supported the finding that IgFLNaΔA20–21 is a mono-
mer in solution, both in the presence and the absence of the migfilin peptide. Furthermore, the
relaxation analysis indicated that the two domains tumble partially independently, both in the
absence and the presence of the peptide.
Discussion
In this study, we have investigated the effect of ligand-binding on the conformation of the
domain pair IgFLNa20–21. In this pair, IgFLNa21 is the highest-affinity binding site in FLN
for many transmembrane protein cytoplasmic domains and for signaling adaptors such as mig-
filin [55]. This site is of considerable interest also because it has been shown to be regulated by
mechanical forces that displace the A strand of IgFLNa20 in the pair, enabling interactions of
IgFLNa21 [10,27].
Based on SAXS analysis, IgFLNa20–21 adopts mainly compact conformations, although a
minor population of extended conformations is also predicted in EOM analysis. EOM-pro-
duced models suggest that the domains are separated in the extended conformations. The com-
pact conformation of IgFLNa20–21 opens upon migfilin peptide-binding. Interestingly, the
maximum dimensions of the peptide-bound IgFLNa20–21 interpose between the compact and
extended forms seen without the bound peptide. Both the EOM analysis and the Kratky plot
show that the ligand-bound IgFLNa20–21 is very flexible. The deletion of the A strand of
domain 20 has a significant influence on the structure of this two-domain fragment. Both ab
initio analysis of SAXS data and EOMmodeling shows that the A strand deletion makes the
IgFLNa20–21 fragment flexible. EOM analyses predicted a bimodal size distribution for
IgFLNaΔA20–21, suggesting that it adopts two different extended conformation states, which
are almost equally populated. The compact conformation seen with IgFLNa20–21 is not
observed at all. EOM-produced models suggest that in both conformations, the domains are
separated but the orientation of the domain-domain linker is altered. Accordingly, the A strand
of domain 20 is needed for the rigidity of the mechanosensory domain pair 20–21. Interest-
ingly, migfilin-binding to IgFLNaΔA20–21 reduces the conformational freedom of
IgFLNaΔA20–21, as EOM produced a unimodal size distribution instead of bimodal, obtained
without bound peptide. It is notable that the EOM-selected conformations for IgFLNaΔA20–
21 with bound peptide are similar to those of IgFLNa20–21.
The crystal structure of IgFLNaΔA20–21 with migfilin peptide showed that migfilin binds
to the CD face and binds to the top of IgFLNa21, displacing IgFLNa20 from the position seen
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in the crystal structure of IgFLNa19–21 [23]. In the crystal structure, the peptide also caused
IgFLNaΔA20–21 to dimerize by being sandwiched between IgFLNa20 and IgFLNa21 of neigh-
boring polypeptide chains. Both the SAXS and the NMRmeasurements revealed that in solu-
tion, intermolecular IgFLNaΔA20–21 complexes are not likely. Therefore, the observed
interaction of IgFLNa20 and migfilin is merely a crystallization artefact.
Combining our results with those reported earlier [8,27,28], we propose a model of three
conformational states for the IgFLNa20–21 mechanosensor module shown in Fig 7A. The
three states are: compact (I), open (II), and ligand-bound (III). SAXS-based EOM analysis
shows that the majority of IgFLNa20–21 adopts a compact conformation (I). The compact
conformation is also seen in the crystal structure of IgFLNa19–21 [23]. In the open state (II),
IgFLNa20 and IgFLNa21 are detached from each other via the flexible domain-domain linker
and form extended structures. In the open form, the domains can fluctuate rather freely in
respect to each other. The open state is most prominent in the IgFLNaΔA20–21 construct
when analyzed without peptide. Similar open conformations have previously also been
obtained by applying external force on FLN [8,27]. Ligands bind either to the open (II) or the
compact form (I), leading to conformations (III) that, based on EOM analysis, are less
extended than the open forms (II). In the crystal structure of IgFLNaΔA20–21 with bound mig-
filin reported here, the migfilin peptide binds on top of IgFLNa21. Accordingly, the peptide-
binding to the top of domain 21 might restrict the mobility of the linker peptide between
IgFLNa20 and IgFLNa21 (Fig 5D), thus preventing FLN to adopt the open conformations (II).
It should be noted that in the crystal structure, only the migfilin residues 6–20 of the total 5–28
used in the crystallization and SAXS experiments are seen. Accordingly, there are eight C-ter-
minal amino acids whose locations are not known based on the crystal structure.
The three conformation states of I, II, and III described above can be predicted to be in equi-
librium exchange (Fig 7A). Although IgFLNa20–21 mainly adopts the compact conformation
I, EOM analysis suggests that a small population of IgFLNa20–21 can also adopt the open con-
formations (II). This is in accordance with recent single-molecule force spectroscopy measure-
ments in which small pN-range external forces shifted the equilibrium between open and
closed states of IgFLNa20–21 towards the open state, but extrapolation to zero force predicted
that occasional opening can take place without force [27]. Peptide-binding to the open confor-
mation is reversible and the dissociation constants are similar to those for individual IgFLNa21,
ranging between 150 nM and 500 μM [16,18,19,23,55]. Recent FRET studies in vitro and in cul-
tured cells have shown that IgFLNa20–21 domain separation can be induced by ligand peptides
as well as by mechanical force [28]. It would be interesting if the FRET probes could be refined
so that the differences in domain distances and the orientations in compact and open confor-
mations could be monitored.
Do other IgFLNa21-binding partners cause ligand-bound conformations of the IgFLNa20–
21 domain pair similar to what we see here with the migfilin peptide? The complex structures
of IgFLNa21 with four different binding partners has been solved [16,18–20]. All of these part-
ners bind similarly to the CD face of IgFLNa21, and the sequence alignment shows at least one
proline and a bulky and charged amino acid immediately following the β-strand-forming resi-
dues (Fig 7B and 7C). The conserved prolines are predicted to bring structural rigidity to the
peptide and thus the alignments and structures suggest that all peptides could restrict move-
ment of IgFLNa20, leading to a similar ligand-bound state as reported here for migfilin. Inter-
estingly, IgFLNa18–19 also adopts an auto-inhibited compact conformation similar to that of
IgFLNa20–21 [24], and IgFLNa19 serves as a binding site for many of the same proteins as
IgFLNa21, albeit with a lower affinity [55]. It is possible that the three-conformational-states
model presented here also holds for IgFLNa18–19.
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In conclusion, both the solution-state modelling and the crystal structure suggest that the
ligand-bound conformations of the IgFLNa20–21 domain pair are unique and differ from the
compact or open conformations. This may be an important feature in the mechanosensor
function of the site.
Fig 7. Peptide binding on IgFLNa20–21. A Amodel of three conformational states for the IgFLNa20–21
mechanosensor module. The compact conformation (I) domain pair interactions are disrupted by the
replacement of the A strand. In open conformations (II) the domains move freely in relation to each other, but
peptide ligand binding (III) restricts the movements. B Sequence alignment of the peptides known to interact
with IgFLNa21 and whose IgFLN complex structures have been determined. C Superimposition of IgFLNa21
(green) structures in complex with peptides: migfilin (yellow), β7-integrin (cyan) [16], β2-integrin (orange) [19],
and CFTR (grey) [20]. Prolines (shown as sticks) at C termini bend the peptides towards the top of IgFLNa21.
The conformation of the CFTR peptide is influenced by crystal packing [20].
doi:10.1371/journal.pone.0136969.g007
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Supporting Information
S1 Fig. Analysis of the concentration dependence of the SAXS data. Raw experimental x-ray
scattering data for each step (1, 2.5, and 4 mg/ml) of the measured concentration series for
IgFLNa20–21 and IgFLNaΔA20–21 with and without peptide. Left panel: the experimental
scattering shown scaled to the same forward scattering intensity I(0). Middle panel: Guinier
analyses arbitrarily placed on the y axis. Right panel: Normalized distance distribution function
P(r).
(TIFF)
S2 Fig. Crystal structure fits to the experimental scattering. Fit of A IgFLNa20–21 (from
IgFLNa19–21 crystal structure, PDB ID: 2J3S [23]) and B IgFLNaΔA20–21+miglifin complex
structure (current structure) to the respective experimental solution scattering profile.
(TIFF)
S3 Fig. Volume-of-correlation Vc normalized Kratky plot.
(TIFF)
S4 Fig. Longitudinal 15N R1 and transverse
15N R2 relaxation rates for free and migfilin-
bound IgFLNaΔA20–21.
(TIFF)
S5 Fig. HSQC spectra of NMRmeasurements. Overlaid HSQC spectra of free IgFLNaΔA20–
21 (red, green for aliased peaks) and IgFLNaΔA20–21 after addition of migfilin peptide at a
ratio of 5:1 peptide to IgFLNaΔA20–21 (blue, cyan). Peaks with Δδ> 0.2 ppm are indicated
with residue numbers.
(TIFF)
S6 Fig. H/D exchange experiments performed for free and migfilin-bound IgFLNaΔA20–
21. AOverlay of HSQC spectra of free IgFLNaΔA20–21 in 95/5% H2O/D2O (red contour) and
in 100% D2O (green contours) after a 18 min sample preparation time. B As in A, but for the
complex form. Peaks in the exchanged spectra are assigned with residue numbers. Residues
2151–2235 form domain ΔA20 and 2236–2329 domain 21. Peaks without assignment have
overlapping or no assignments in the reference spectra. C–D Exchange protected residues
mapped on the structures of the free (PDB ID: 2J3S) and bound form, respectively. Strand A in
the free form and migfilin peptide in the bound form are shown in yellow.
(TIFF)
S1 Table. SAXS data collection parameters and data analysis software.
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S2 Table. SAXS-derived sample parameters.
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